Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy.

Expert Opin Biol Ther

Translational Research, Trillium Therapeutics Inc., Mississaugua, Ontario, Canada.

Published: January 2020

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2020.1685976DOI Listing

Publication Analysis

Top Keywords

blockade cd47-sirpα
4
cd47-sirpα axis
4
axis promising
4
promising approach
4
approach cancer
4
cancer immunotherapy
4
blockade
1
axis
1
promising
1
approach
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!